Cover image

Nanotheranostics, the sister journal of Theranostics, is a multidisciplinary and fully open access journal. Currently, the journal does not charge any publication or submission fees (Platinum open access). Nanotheranostics publishes innovative and original basic, translational and clinical research reflecting the fields of nanomedicine, nanoimaging, drug and gene delivery, nanoelectronic biosensors, and other areas. 

Regular features include high quality research articles, reviews or mini-reviews, rapid communication of preliminary data on innovative research, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical studies or ethical issues of nanomedicine are also welcome. Timely reviews that provide updates on current applications and issues in nanomedicine and translational aspects of nanotheranostics and other topics are particularly welcome and will be given high priority.

Nanotheranostics employs a rigorous peer-review system, but also strives for rapid review turnaround times and is based on the same streamlined submission platform as Theranostics.

Recent Papers:


Graphic abstract

Research Paper
A Rapid, Convergent Approach to the Identification of Exosome Inhibitors in Breast Cancer Models
Zoraida Andreu, Esther Masiá, David Charbonnier, María J. Vicent
Nanotheranostics 2023; 7(1): 1-21. doi:10.7150/ntno.73606
[Abstract] [Full text] [PDF]


Graphic abstract

Research Paper
Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma model
Md. Rakibul Islam, Jalpa Patel, Patricia Ines Back, Hilary Shmeeda, Konstantin Adamsky, Hui Yang, Carlos Alvarez, Alberto A. Gabizon, Ninh M. La-Beck
Nanotheranostics 2022; 6(4): 451-464. doi:10.7150/ntno.75045
[Abstract] [Full text] [PDF] [PubMed] [PMC]


Graphic abstract

Review
Progress on Applying Carbon Dots for Inhibition of RNA Virus Infection
Yaung Kwee, Yiqun Zhou, Mochamad Zakki Fahmi, Madhuri Sharon, Alfinda Novi Kristanti
Nanotheranostics 2022; 6(4): 436-450. doi:10.7150/ntno.73918
[Abstract] [Full text] [PDF] [PubMed] [PMC]


Graphic abstract

Research Paper
Stealth Liposomal Chemotherapeutic Agent for Triple Negative Breast Cancer with Improved Pharmacokinetics
Nagavendra Kommineni, David Paul, Raju Saka, Wahid Khan, Satheeshkumar Nanjappan
Nanotheranostics 2022; 6(4): 424-435. doi:10.7150/ntno.76370
[Abstract] [Full text] [PDF] [PubMed] [PMC]


Graphic abstract

Review
Nanotechnology Advances in the Detection and Treatment of Cancer: An Overview
Sareh Mosleh-Shirazi, Milad Abbasi, Mohammad reza Moaddeli, Ahmad Vaez, Mostafa Shafiee, Seyed Reza Kasaee, Ali Mohammad Amani, Saeid Hatam
Nanotheranostics 2022; 6(4): 400-423. doi:10.7150/ntno.74613
[Abstract] [Full text] [PDF] [PubMed] [PMC]


Graphic abstract

Research Paper
Covalent core-radiolabeling of polymeric micelles with 125I/211At for theranostic radiotherapy
Emanuel Sporer, Christian B. M. Poulie, Tom Bäck, Sture Lindegren, Holger Jensen, Paul J. Kempen, Andreas Kjaer, Matthias M. Herth, Andreas I. Jensen
Nanotheranostics 2022; 6(4): 388-399. doi:10.7150/ntno.71906
[Abstract] [Full text] [PDF] [PubMed] [PMC]


Graphic abstract

Research Paper
Ultrasound-triggered oxygen-loaded nanodroplets enhance and monitor cerebral damage from sonodynamic therapy
Harriet Lea-Banks, Sheng-Kai Wu, Hannah Lee, Kullervo Hynynen
Nanotheranostics 2022; 6(4): 376-387. doi:10.7150/ntno.71946
[Abstract] [Full text] [PDF] [PubMed] [PMC]


Graphic abstract

Review
Emerging Role of Edible Exosomes-Like Nanoparticles (ELNs) as Hepatoprotective Agents
P. Debishree Subudhi, Chhagan Bihari, Shiv Kumar Sarin, Sukriti Baweja
Nanotheranostics 2022; 6(4): 365-375. doi:10.7150/ntno.70999
[Abstract] [Full text] [PDF] [PubMed] [PMC]

More ...

Editor-in-Chief:
Jonathan Lovell, PhD
Associate Professor, Biomedical Engineering
University at Buffalo, State University of New York
newCFP: Special Issue: Interventional Nanotheranostics for targeted imaging and combination therapeutics. Guest Editor: Rajendra Prasad, PhD, MRSC, Department of Mechanical Engineering, Tufts University.
Nanotheranostics is now indexed in the Web of Science, Biological Abstracts and BIOSIS Previews.

Nanotheranostics has been selected by The Literature Selection Technical Review Committee (LSTRC) for inclusion in MEDLINE, the prestigious index of U.S. National Library of Medicine.

Gold nanorods (GNRs) have attracted great interest for photo-mediated biomedicines due to their tunable and high optical absorption, high photothermal conversion efficiency and facile surface modifiability. GNRs that have efficient absorption in second near-infrared (NIR-II) window hold further promise in bio-applications due to low background signal from tissue and deep tissue penetration. However, bare GNRs readily undergo shape deformation (termed as 'melting effect') during the laser illumination losing their unique localized surface plasmon resonance (LSPR) properties, which subsequently leads....
'See what you treat and treat what you see, at a molecular level', could be the motto of theranostics. The concept implies diagnosis (imaging) and treatment of cells (usually cancer) using the same molecule, thus guaranteeing a targeted cytotoxic approach of the imaged tumor cells while sparing healthy tissues. As the brilliant late Sam Gambhir would say, the imaging agent acts like a 'molecular spy' and reveals where the tumoral cells are located and the extent of disease burden (diagnosis). For treatment, the same 'molecular spy' docks to the same tumor cells, this time delivering cytotoxic doses....
Cognitive impairment is a common aspect of multiple sclerosis (MS) for which there are no treatments. Reduced brain N-acetylaspartylglutamate (NAAG) levels are linked to impaired cognition in various neurological diseases, including MS. NAAG levels are regulated by glutamate carboxypeptidase II (GCPII), which hydrolyzes the neuropeptide to N-acetyl-aspartate and glutamate. GCPII activity is upregulated multifold in microglia following neuroinflammation. Although several GCPII inhibitors, such as 2-PMPA, elevate brain NAAG levels and restore cognitive function in preclinical studies when given at....
Rationale: To assess treatment effects of 4 complementary miRNAs (miRNA-100/miRNA-122/antimiRNA-10b/antimiRNA-21) encapsulated in a biodegradable PLGA-PEG nanoparticle, administered by an ultrasound-guided microbubble-mediated targeted delivery (UGMMTD) approach in mouse models of hepatocellular carcinoma (HCC). Methods: In vitro apoptotic index was measured in HepG2 and Hepa1-6 HCC cells treated with various combinations of the 4 miRNAs with doxorubicin. Three promising combinations were further tested in vivo by using UGMMTD. 63 HepG2 xenografts in mice were randomized into: group 1, miRNA-122/antimiRNA-10b/antimiRNA-21/US/doxorubicin;....
Congratulations to Dr. Chen for being elected as AIMBE fellow.